| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0033291719001685 |
| P698 | PubMed publication ID | 31284882 |
| P50 | author | Emre Bora | Q56928700 |
| P2860 | cites work | Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia | Q26766071 |
| Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment | Q26781620 | ||
| The global cognitive impairment in schizophrenia: consistent over decades and around the world | Q27000334 | ||
| Inflammation and schizophrenia | Q27002489 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
| Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond | Q33566114 | ||
| Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? | Q33762467 | ||
| Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis. | Q34548501 | ||
| The interplay of stress and sleep impacts BDNF level | Q35022602 | ||
| BDNF gene effects on brain circuitry replicated in 455 twins | Q35340468 | ||
| Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls. | Q35950787 | ||
| The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis | Q35955612 | ||
| Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups | Q36113651 | ||
| Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? | Q36404577 | ||
| Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review | Q36625363 | ||
| Neurocognition in first-episode schizophrenia: a meta-analytic review | Q37468973 | ||
| TrkB signalling pathways in LTP and learning | Q37635759 | ||
| The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis | Q37771567 | ||
| Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis | Q38119735 | ||
| Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings | Q38124448 | ||
| C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls | Q58575852 | ||
| C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review | Q58712660 | ||
| Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia | Q59784211 | ||
| Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis | Q60629571 | ||
| The emerging role of exosomes in mental disorders | Q64109767 | ||
| Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis | Q80574459 | ||
| Reduced brain-derived neurotrophic factor is associated with childhood trauma experiences and number of depressive episodes in severe mental disorders | Q91046189 | ||
| Neuroinflammation and cognition across psychiatric conditions | Q91326902 | ||
| Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis. | Q38194586 | ||
| Inflammatory mediators of cognitive impairment in bipolar disorder | Q38215023 | ||
| Neuroinflammation and white matter pathology in schizophrenia: systematic review. | Q38221829 | ||
| Regulation of hippocampal synaptic plasticity by BDNF. | Q38275797 | ||
| Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis | Q38355176 | ||
| Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset | Q38392954 | ||
| Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia. | Q38449239 | ||
| Cognitive Impairment in Schizophrenia: Interplay of BDNF and Childhood Trauma? A Review of Literature | Q38646805 | ||
| Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor | Q38710510 | ||
| Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia. | Q38991584 | ||
| The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis. | Q39061995 | ||
| Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review | Q39246642 | ||
| Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis. | Q39281301 | ||
| Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia | Q43233856 | ||
| Childhood trauma and cognitive function in first-episode affective and non-affective psychosis | Q43645782 | ||
| Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia | Q45361984 | ||
| Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis | Q46888485 | ||
| BDNF Val66Met polymorphism modulates the effect of loneliness on white matter microstructure in young adults | Q47567622 | ||
| Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates | Q47612848 | ||
| Developmental Differences Between Schizophrenia and Bipolar Disorder | Q47649952 | ||
| A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression | Q48063321 | ||
| Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia | Q48128316 | ||
| Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications | Q48507006 | ||
| Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy | Q48626032 | ||
| Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia | Q48694105 | ||
| Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia | Q48890957 | ||
| C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia | Q50195584 | ||
| Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia | Q50421833 | ||
| C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. | Q50578956 | ||
| Neurodevelopmental origin of cognitive impairment in schizophrenia. | Q50645808 | ||
| Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. | Q52038454 | ||
| Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations. | Q54237101 | ||
| Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia | Q57133155 | ||
| Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes | Q57191834 | ||
| P433 | issue | 12 | |
| P921 | main subject | schizophrenia | Q41112 |
| meta-analysis | Q815382 | ||
| biomarker | Q864574 | ||
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 1971-1979 | |
| P577 | publication date | 2019-07-09 | |
| P1433 | published in | Psychological Medicine | Q7256364 |
| P1476 | title | Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis | |
| P478 | volume | 49 |
| Q95937928 | Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients |
| Q90310996 | Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study |
| Q96133510 | Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis - CORRIGENDUM |
Search more.